{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:15:18Z","timestamp":1787498118819,"version":"build-2736575974"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2020.00093","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T11:24:34Z","timestamp":1589282674000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Extracellular Sortilin Proteopathy Relative to \u03b2-Amyloid and Tau in Aged and Alzheimer\u2019s Disease Human Brains"],"prefix":"10.3389","volume":"12","author":[{"given":"Tian","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Manavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly.","volume":"6","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00401-008-0358-2","article-title":"Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium.","volume":"115","author":"Alafuzoff","year":"2008","journal-title":"Acta Neuropathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/0304-3940(86)90152-7","article-title":"Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer\u2019s disease.","volume":"68","author":"Allsop","year":"1986","journal-title":"Neurosci. Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report.","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat. Med."},{"key":"B5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease.","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community based studies.","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-014-1373-0","article-title":"Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer\u2019s disease or corticobasal degeneration brains.","volume":"129","author":"Boluda","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00401-014-1308-9","article-title":"A comparison of A\u03b2 amyloid pathology staging systems and correlation with clinical diagnosis.","volume":"128","author":"Boluda","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-014-1356-1","article-title":"Are cases with tau pathology occurring in the absence of A\u03b2 deposits part of the AD-related pathological process?","volume":"128","author":"Braak","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1212\/WNL.0000000000004059","article-title":"Functional network integrity presages cognitive decline in preclinical Alzheimer disease.","volume":"89","author":"Buckley","year":"2017","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1460-9568.2010.07376.x","article-title":"\u03b2-Secretase-1 elevation in aged monkey and Alzheimer\u2019s disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and \u03b2-amyloid accumulation.","volume":"32","author":"Cai","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/00005072-199606000-00004","article-title":"Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer\u2019s disease and Down\u2019s syndrome.","volume":"55","author":"Cataldo","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging.","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/jnnp.s1-10.38.124","article-title":"Critical review: the nature and significance of senile plaques.","volume":"10","author":"Critchley","year":"1929","journal-title":"J. Neurol. Psychopathol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0518-8","article-title":"Tau and atrophy: domain-specific relationships with cognition.","volume":"11","author":"Digma","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"B18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JAD-2007-12206","article-title":"Cajal\u2019s contributions to the study of Alzheimer\u2019s disease.","volume":"12","author":"Garc\u00eda-Mar\u00edn","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/00005072-199712000-00011","article-title":"Diffuse plaques in the striatum in Alzheimer disease (AD): relationship to the striatal mosaic and selected neuropeptide markers.","volume":"56","author":"Gearing","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/s0006-291x(84)80190-4","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","article-title":"In vivo staging of regional amyloid deposition.","volume":"89","author":"Grothe","year":"2017","journal-title":"Neurology"},{"key":"B22","first-page":"1075","article-title":"The neuropathological changes associated with normal brain aging.","volume":"11","author":"Hof","year":"1996","journal-title":"Histol. Histopathol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2017.00045","article-title":"Sortilin fragments deposit at senile plaques in human cerebrum.","volume":"11","author":"Hu","year":"2017","journal-title":"Front. Neuroanat."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease.","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement."},{"key":"B25","first-page":"1823","article-title":"Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques.","volume":"149","author":"Iwatsubo","year":"1996","journal-title":"Am. J. Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease.","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"B28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-7091-7508-8_8","article-title":"Neuropathology of Alzheimer\u2019s disease:critical update.","volume":"54","author":"Jellinger","year":"1998","journal-title":"J. Neural Transm. Suppl."},{"key":"B29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease.","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4132\/jptm.2019.03.14","article-title":"Primary age-related tauopathy: an elderly brain pathology frequently encountered during autopsy.","volume":"53","author":"Kim","year":"2019","journal-title":"J. Pathol. Transl. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies.","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1093\/brain\/awz154","article-title":"Alzheimer\u2019s pathology targets distinct memory networks in the ageing brain.","volume":"142","author":"Maass","year":"2019","journal-title":"Brain"},{"key":"B33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ana.410400205","article-title":"Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer\u2019s disease: predominance of Abeta42(43).","volume":"40","author":"Mann","year":"1996","journal-title":"Ann. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome.","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jalz.2018.12.001","article-title":"Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer\u2019s disease.","volume":"15","author":"Mattsson","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease.","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach.","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-019-02054-4","article-title":"The basis of cellular and regional vulnerability in Alzheimer\u2019s disease.","volume":"138","author":"Mrdjen","year":"2019","journal-title":"Acta Neuropathol."},{"key":"B40","first-page":"1545","article-title":"Teofil Simchowicz (1879-1957): the scientist who coined senile plaques in neuropathology.","volume":"56","author":"Ohry","year":"2015","journal-title":"Rom. J. Morphol. Embryol."},{"key":"B41","first-page":"1041","article-title":"Senile cerebral amyloidosis.","volume":"73","author":"Oifa","year":"1973","journal-title":"Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova."},{"key":"B42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease.","volume":"15","author":"Panza","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/ADR-190121","article-title":"Medial temporal lobe disconnection and hyperexcitability across Alzheimer\u2019s disease stages.","volume":"3","author":"Pasquini","year":"2019","journal-title":"J. Alzheimers Dis. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0197-4580(91)90006-6","article-title":"The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer\u2019s disease.","volume":"12","author":"Price","year":"1991","journal-title":"Neurobiol. Aging"},{"key":"B45","first-page":"35370","article-title":"C99 selectively accumulates in vulnerable neurons in Alzheimer\u2019s disease.","volume":"19","author":"Pulina","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B46","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12264-018-0306-7","article-title":"Standardized operational protocol for human brain banking in China.","volume":"35","author":"Qiu","year":"2019","journal-title":"Neurosci. Bull."},{"key":"B47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","article-title":"Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased A\u03b2 generation in Alzheimer\u2019s disease.","volume":"132","author":"Sadleir","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.dadm.2018.01.006","article-title":"Topographic staging of tau positron emission tomography images.","volume":"10","author":"Schwarz","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease.","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/jnen\/nlw026","article-title":"Thal amyloid stages do not significantly impact the correlation between neuropathological change and cognition in the Alzheimer disease continuum.","volume":"75","author":"Serrano-Pozo","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3233\/JAD-2010-100846","article-title":"Is brain amyloid production a cause or a result of dementia of the Alzheimer\u2019s type?","volume":"22","author":"Struble","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0006-8993(95)00162-j","article-title":"Amyloid beta protein 1-42\/43 (A beta 1-42\/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study.","volume":"679","author":"Tamaoka","year":"1995","journal-title":"Brain Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","article-title":"Phases of A beta-deposition in the humanbrain and its relevance for the development of AD.","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neurobiolaging.2017.10.002","article-title":"Early Alzheimer-type lesions in cognitively normal subjects.","volume":"62","author":"Tsartsalis","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"B55","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jalz.2018.08.005","article-title":"Understanding disease progression and improving Alzheimer\u2019s disease clinical trials: recent highlights from the Alzheimer\u2019s disease neuroimaging initiative.","volume":"15","author":"Veitch","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B56","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","article-title":"Duration of preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease in relation to age, sex, and APOE genotype.","volume":"15","author":"Vermunt","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-016-0355-3","article-title":"Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer\u2019s disease.","volume":"8","author":"Wang","year":"2016","journal-title":"Genome Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1139\/bcb-2018-0023","article-title":"Sortilin: a new player in dementia and Alzheimer-type neuropathology.","volume":"96","author":"Xu","year":"2018","journal-title":"Biochem. Cell Biol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2019.00031","article-title":"Regional and cellular mapping of sortilin immunoreactivity in adult human brain.","volume":"13","author":"Xu","year":"2019","journal-title":"Front. Neuroanat."},{"key":"B60","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/bf00689591","article-title":"A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining.","volume":"76","author":"Yamaguchi","year":"1988","journal-title":"Acta Neuropathol."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048782","article-title":"Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3\u00d7Tg-AD mice.","volume":"7","author":"Yan","year":"2012","journal-title":"PLoS One"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(14)70259-5","article-title":"Brain banking as a cornerstone of neuroscience in China.","volume":"14","author":"Yan","year":"2015","journal-title":"Lancet Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3233\/JAD-131400","article-title":"Can BACE1 inhibition mitigate early axonal pathology in neurological diseases?","volume":"38","author":"Yan","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1111\/j.1460-9568.2009.07017.x","article-title":"Beta-secretase-1 elevation in transgenic mouse models of Alzheimer\u2019s disease is associated with synaptic\/axonal pathology and amyloidogenesis: implications for neuritic plaque development.","volume":"30","author":"Zhang","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0370-2","article-title":"Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer\u2019s disease model mice and macaques.","volume":"10","author":"Zhou","year":"2018","journal-title":"Alzheimers Res. Ther."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2020.00093\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T11:24:42Z","timestamp":1589282682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2020.00093\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":65,"alternative-id":["10.3389\/fnagi.2020.00093"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2020.00093","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"article-number":"93"}}